U.S. House Democrats question if Valeant is wrongfully withholding records

WASHINGTON, April 26 (Reuters) - Democrats on a powerful

U.S. congressional panel are questioning whether Canada-based

Valeant Pharmaceuticals may be wrongfully withholding

documents in connection with its ongoing probe into

sky-rocketing drug prices, according to an internal memo seen by

Reuters on Tuesday.

Read more